Literature DB >> 32842855

Upregulation of oxidative stress-responsive 1(OXSR1) predicts poor prognosis and promotes hepatocellular carcinoma progression.

Jianhui Chen1,2, Jiangfan Zhou3, Haotian Fu2, Xiaofeng Ni1,2, Yunfeng Shan2.   

Abstract

Many studies reported that Oxidative stress-responsive 1(OXSR1) is closely related to the malignant progression of several malignancies. Nevertheless, the expression pattern and function of OXSR1 in HCC remains unknown. In present research, it was observed that the expression of OXSR1 was abnormally elevated in HCC. Upregulated OXSR1 was associated with TNM stage, and grade and was confirmed as an independent prognostic factor in HCC patients. The downregulation of OXSR1 expression effectively repressed the proliferation, migration and invasion of HCC in vivo and in vitro experiments. Western blot and qRT-PCR analysis demonstrated that mutant p53-R249S was critical for regulating the aberrant elevation of OXSR1 in HCC. Chip assay indicated that p53-R249S abrogated the binding of p53 to the OXSR1 promoter region and increased the level of POL2, H3Kac and H4Kac in the promoter region of the OXSR1, thus promoting the transcriptional expression of OXSR1. GSEA revealed that numerous cancer-related pathways were enriched in the high OXSR1 expression group. Furthermore, the expression level of OXSR1 was positively correlated with the infiltration levels of tumor infiltrating immune cells (TIICs) and PD-L1 expression in HCC by TIMER platform. In summary, our study revealed that upregulated OXSR1 was a determinant of prognosis and immune infiltration in HCC. The expression of OXSR1 was released by p53-R249S mutant, and upregulated OXSR1 in HCC promoted proliferation, migration and invasion.

Entities:  

Keywords:  Oxidative stress-responsive 1; hepatocellular carcinoma; immune infiltration; p53-R249S

Year:  2020        PMID: 32842855      PMCID: PMC8291867          DOI: 10.1080/21655979.2020.1814659

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  7 in total

1.  LncRNA ZFAS1 regulates the hippocampal neurons injury in epilepsy through the miR-15a-5p/OXSR1/NF-κB pathway.

Authors:  Zengmian Wang; Zhimin Na; Ying Cui; Chunjie Wei; Shuqiu Wang
Journal:  Metab Brain Dis       Date:  2022-06-25       Impact factor: 3.655

Review 2.  Hypoxia, oxidative stress, and immune evasion: a trinity of the trichothecenes T-2 toxin and deoxynivalenol (DON).

Authors:  Li You; Yingying Zhao; Kamil Kuca; Xu Wang; Patrik Oleksak; Zofia Chrienova; Eugenie Nepovimova; Vesna Jaćević; Qinghua Wu; Wenda Wu
Journal:  Arch Toxicol       Date:  2021-03-25       Impact factor: 5.153

3.  Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury.

Authors:  Heyun Li; Xia Zhang; Peng Wang; Xiaoyan Zhou; Haiying Liang; Caoni Li
Journal:  Diabetol Metab Syndr       Date:  2021-01-19       Impact factor: 3.320

4.  System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.

Authors:  Jun Hui Xu; Yong Jun Guan; Zhen Dong Qiu; Xin Zhang; Liu Liu Zi; Yu Zhou; Chen Chen; Jia Yu; Yi Chao Zhang; Wei Xing Wang
Journal:  Oxid Med Cell Longev       Date:  2021-11-08       Impact factor: 6.543

5.  Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.

Authors:  Changjing Huang; Chenyue Zhang; Jie Sheng; Dan Wang; Yingke Zhao; Ling Qian; Lin Xie; Zhiqiang Meng
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

6.  Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression.

Authors:  Yingying Nie; Xuedan Zhu; Nan Bu; Yang Jiang; Yue Su; Keming Pan; Shanshan Li
Journal:  BMC Cancer       Date:  2022-03-14       Impact factor: 4.430

7.  Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.

Authors:  Xiaoyue Ren; Alex Li; Edward Ying; Jhin Fang; Mingzhu Li; Jiao Yu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.